Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Plasma versus Whole Blood Tacrolimus Concentration and Outcomes After Kidney Transplantation: Post Hoc Analysis of the ALLEGRO Trial.

BACKGROUND Tacrolimus is the cornerstone of immunosuppressive treatment after kidney transplantation. Its application requires therapeutic drug monitoring, which is routinely performed by assessment of whole blood tacrolimus concentrations (WBTC) that largely comprises a pharmacologically inactive fraction. Monitoring...

J. Jonker, J. C. van den Born, D. Kremer et al. · 0 citations
Review Jul 2026

Health-Related Quality of Life in Clinical Trials of CKD Progression: A Scoping Review.

The impact of disease-modifying therapies on HRQoL in non-dialysis CKD is heterogeneous, instrument-dependent, and domain-specific; future trials should incorporate kidney-specific HRQoL instruments and report results for all domains using multiple effect measures.

Chang-Yuan Yang, Devika Nair, P. Vart · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.